Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
The identification and validation of biomarkers for clinical applications remains an important issue for improving diagnostics and therapy in many diseases, including prostate cancer. Gene expression profiles are routinely applied to identify diagnostic and predictive biomarkers or novel targets for...
Main Authors: | Saeid Alinezhad, Riina-Minna Väänänen, Jesse Mattsson, Yifeng Li, Terhi Tallgrén, Natalia Tong Ochoa, Anders Bjartell, Malin Åkerfelt, Pekka Taimen, Peter J Boström, Kim Pettersson, Matthias Nees |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4873225?pdf=render |
Similar Items
-
Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
by: Saeid Alinezhad, et al.
Published: (2016-01-01) -
A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues
by: Ilmari Ahonen, et al.
Published: (2017-07-01) -
Segmentation of Image Data from Complex Organotypic 3D Models of Cancer Tissues with Markov Random Fields.
by: Sean Robinson, et al.
Published: (2015-01-01) -
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
by: Nataliia Petruk, et al.
Published: (2021-03-01) -
Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression.
by: Irena Saarinen, et al.
Published: (2015-01-01)